View More View Less
  • 1 Bács-Kiskun County Teaching Hospital Department of Hospital Hygiene Kecskemét Hungary
  • | 2 Bács-Kiskun County Teaching Hospital Department of Pathology Kecskemét Hungary
  • | 3 Bács-Kiskun County Teaching Hospital Department of Oral and Maxillofacial Surgery and Otorhinolaryngology Kecskemét Hungary
  • | 4 Bács-Kiskun County Teaching Hospital Central Intensive Care Unit Kecskemét Hungary
  • | 5 Semmelweis University Clinical Microbiology Diagnostic Laboratory, Institute of Laboratory Medicine Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

In polymorbid or anaemic patients who receive preoperative radiotherapy or undergo long duration surgery involving potentially infectious sites, perioperative antibiotic prophylaxis (PAP) that is effective against normal oral bacterial flora is mandatory and plays an important role in preventing postoperative infection. In a four-year retrospective analysis, the incidence, outcome, and the efficacy of PAP were evaluated in patients treated at the Department of Oral and Maxillofacial Surgery and Otorhinolaryngology at Kecskemét Hospital. The results were compared with data from the literature to determine if the use of PAP was adequate at the Department.During the study period (between 01/09/2007 and 31/01/2011) 108 patients were evaluated. The mean duration of prophylactic antibiotic treatment was 8.3 ± 5.2 days, with cefotaxime+metronidazole being the most commonly used combination. Surgical site infection occurred in 8 patients (7.5%) in the clean-contaminated category.Our results showed that the perioperative antibiotic prophylaxis administered at our Department was efficient and effective against the oral bacterial flora of patients. Its use is recommended in head and neck microsurgery. To avoid development of antibiotic resistance and to reduce costs, it seems that the duration of antibiotic regimen for primary surgery can be reduced from 8.3 ± 5.2 days to 3 days.

  • Pang, L., Jeannon, J.P., Simo, R.: Minimizing complications in salvage head and neck oncological surgery following radiotherapy and chemo-radiotherapy. Curr Opin Otolaryngol Head Neck Sur 19, 125–131 (2011).

    Simo R. , 'Minimizing complications in salvage head and neck oncological surgery following radiotherapy and chemo-radiotherapy ' (2011 ) 19 Curr Opin Otolaryngol Head Neck Sur : 125 -131.

    • Search Google Scholar
  • Ludwig, E., Szalka, A.: Infektologia. Medicina, Budapest, 2009, pp. 460–473.

    Szalka A. , '', in Infektologia , (2009 ) -.

  • Becker, G.D., Perral, G.J.: Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngo 88, 183–186 (1979).

    Perral G.J. , 'Cefazolin prophylaxis in head and neck cancer surgery ' (1979 ) 88 Ann Otol Rhinol Laryngo : 183 -186.

    • Search Google Scholar
  • Weber, R.S., Callender, D.L.: Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol Suppl 155, 16–20 (1992).

    Callender D.L. , 'Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery ' (1992 ) 155 Ann Otol Rhinol Laryngol Suppl : 16 -20.

    • Search Google Scholar
  • Simo, R., French, G.: The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Sur 14, 55–61 (2006).

    French G. , 'The use of prophylactic antibiotics in head and neck oncological surgery ' (2006 ) 14 Curr Opin Otolaryngol Head Neck Sur : 55 -61.

    • Search Google Scholar
  • Righi, M., Manfredi, R., Farneti, G., Pasquini, E., Buglari, D.R., Cenacchi, V.: Clindamycin/cefonicid in head and neck surgery: One-day prophylaxis is as effective as a three-day schedule. J Chemotherapy 7, 216–220 (1995).

    Cenacchi V. , 'Clindamycin/cefonicid in head and neck surgery: One-day prophylaxis is as effective as a three-day schedule ' (1995 ) 7 J Chemotherapy : 216 -220.

    • Search Google Scholar
  • Johansen, L.V., Overgaard, J., Elbrond, O.: Pharyngo-cutenous fistule after laryngectomy: influence of previous radiotherapy and prophylactic metronidazole. Cancer 61, 673–678 (1988).

    Elbrond O. , 'Pharyngo-cutenous fistule after laryngectomy: influence of previous radiotherapy and prophylactic metronidazole ' (1988 ) 61 Cancer : 673 -678.

    • Search Google Scholar
  • Geyer, G., Borneff, M., Hartmetz, G.: Perioperative Prophylaxis mit Cefmenoxim und Metroniodazol bei Patienten mit Kopf-Hals-Tumoren. HNO 35, 355–359 (1987).

    Hartmetz G. , 'Perioperative Prophylaxis mit Cefmenoxim und Metroniodazol bei Patienten mit Kopf-Hals-Tumoren ' (1987 ) 35 HNO : 355 -359.

    • Search Google Scholar
  • Grandis, J.R., Vickers, R.M., Rihs, R.M., Yu, V.L., Wagner, R.L., Kachman, K.K., Johnson, J.T.: The efficacy of topical antibiotic prophylaxis for contaminated head and neck surgery. Laryngoscope 104, 719–724 (1994).

    Johnson J.T. , 'The efficacy of topical antibiotic prophylaxis for contaminated head and neck surgery ' (1994 ) 104 Laryngoscope : 719 -724.

    • Search Google Scholar
  • Carroll, W.R., Rosenstiel, D., Fix, J.R., de la Torre, J., Solomon, J.S., Brodish, B., Rosenthal, E.L., Heinz, T., Niwas, S., Peters, G.E.: Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Sur 129, 771–774 (2003).

    Peters G.E. , 'Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck ' (2003 ) 129 Arch Otolaryngol Head Neck Sur : 771 -774.

    • Search Google Scholar
  • Pál, T.: Az orvosi mikrobiológia tankönyve. Mecinina Könyvkiadó Zrt., Budapest, 2012.

    Pál T. , '', in Az orvosi mikrobiológia tankönyve , (2012 ) -.

  • Fraioli, R., Johnson, J.T.: Prevention and treatment of postsurgical head and neck infections. Current Infectious Disease Reports 6, 172–180 (2004).

    Johnson J.T. , 'Prevention and treatment of postsurgical head and neck infections ' (2004 ) 6 Current Infectious Disease Reports : 172 -180.

    • Search Google Scholar
  • Clayman, G.L., Raad, I.I., Hankins, P.D., Weber, R.S.: Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 15, 526–531 (1993).

    Weber R.S. , 'Bacteriologic profile of surgical infection after antibiotic prophylaxis ' (1993 ) 15 Head Neck : 526 -531.

    • Search Google Scholar
  • Brook, I., Hirokawa, R.: Microbiology of wound infection after head and neck cancer surgery. Ann Otol Rhinol Laryngol 98, 323–325 (1989).

    Hirokawa R. , 'Microbiology of wound infection after head and neck cancer surgery ' (1989 ) 98 Ann Otol Rhinol Laryngol : 323 -325.

    • Search Google Scholar
  • Brook, I.: Diagnosis and management of anaerobic infections of the head and neck. Ann Otol Rhinol Laryngol Suppl 155, 9–15 (1992).

    Brook I. , 'Diagnosis and management of anaerobic infections of the head and neck ' (1992 ) 155 Ann Otol Rhinol Laryngol Suppl : 9 -15.

    • Search Google Scholar
  • Grandis, R.J., Snyderman, C.H., Johnson, J.T., Yu, V.L., D’Amico, F.: Postoperative wound infection. A poor prognostic sign for patients with head and neck cancer. Cancer 70, 2166–2170 (1992).

    D’Amico F. , 'Postoperative wound infection. A poor prognostic sign for patients with head and neck cancer ' (1992 ) 70 Cancer : 2166 -2170.

    • Search Google Scholar
  • Skitarelic, N., Morovic, M., Manestar, D.: Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Cranio Maxill Surg 35, 15–20 (2007).

    Manestar D. , 'Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery ' (2007 ) 35 J Cranio Maxill Surg : 15 -20.

    • Search Google Scholar
  • Scarpese, S.L., Brodzik, F.A., Mehdi, S., Belgam, R.: Treatment of head and neck cancers: Issues for clinical pharmacists. Pharmacotherap 29, 578–592 (2009).

    Belgam R. , 'Treatment of head and neck cancers: Issues for clinical pharmacists ' (2009 ) 29 Pharmacotherap : 578 -592.

    • Search Google Scholar
  • Arnold, D.J., Goodwin, W.J., Weed, D.T., Civantos, F.J.: Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck. Seminars in Radiation. Oncology 14, 190–195 (2004).

    Civantos F.J. , 'Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck. Seminars in Radiation ' (2004 ) 14 Oncology : 190 -195.

    • Search Google Scholar
  • Lim, J.Y., Lim, Y.C., Kim, S.H., Byeon, H.K., Choi, E.C.: Factors predictive of successful outcome following salvage treatment of isolated neck recurrences. Otolaryngol Head Neck Surg 142, 832–837 (2010).

    Choi E.C. , 'Factors predictive of successful outcome following salvage treatment of isolated neck recurrences ' (2010 ) 142 Otolaryngol Head Neck Surg : 832 -837.

    • Search Google Scholar
  • Girod, D.A, McCulloch, T.M., Tsue, T.T., Weymuller, E.A.: Risk factors for complications in clean-contaminated head and neck surgical procedures. Head Neck Surg 17, 7–13 (1995).

    Weymuller E.A. , 'Risk factors for complications in clean-contaminated head and neck surgical procedures ' (1995 ) 17 Head Neck Surg : 7 -13.

    • Search Google Scholar
  • Mangram, A.J., Horan, T.C., Pearson, M.L., Silver, L.C., Jarvis, W.R.: Guideline for prevention of surgical site infection, 1999. Am J Infect Control 27, 97–134 (1999).

    Jarvis W.R. , 'Guideline for prevention of surgical site infection, 1999 ' (1999 ) 27 Am J Infect Control : 97 -134.

    • Search Google Scholar
  • Agra, I.M., Carvalho, A.L., Pontes, E., Campos, O.D., Ulbrich, F.S., Magrin, J., Kowalski, L.P.: Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg 129, 1317–1321 (2003).

    Kowalski L.P. , 'Postoperative complications after en bloc salvage surgery for head and neck cancer ' (2003 ) 129 Arch Otolaryngol Head Neck Surg : 1317 -1321.

    • Search Google Scholar
  • Steinberg, J.P., Braun, B.I., Hellinger, W.C., Kusek, L., Bozikis, M.R., Bush, A.J., Dellinger, E.P., Burke, J.P., Simmons, B., Kritchevsky, S.B.: Timing of antimicrobial prophylaxis and the risk of surgical site infections. Ann Surg 250, 10–16 (2009).

    Kritchevsky S.B. , 'Timing of antimicrobial prophylaxis and the risk of surgical site infections ' (2009 ) 250 Ann Surg : 10 -16.

    • Search Google Scholar
  • Alexander, J.W., Solomkin, J.S., Edwards, M.J.: Updated Recommendations for Control of Surgical Site Infections. http://www.medscape.com/viewarticle/742992 April 02.2012

    Edwards M.J. , '', in Updated Recommendations for Control of Surgical Site Infections , (2012 ) -.

  • Reiffel, A.J., Kamdar, M.R., Kadouch, D.J., Rohde, C.H., Spector, J.A.: Perioperative antibiotics in the setting of microvascular free tissue transfer: Current practices. J Reconstr Microsurg 26, 401–407 (2010).

    Spector J.A. , 'Perioperative antibiotics in the setting of microvascular free tissue transfer: Current practices ' (2010 ) 26 J Reconstr Microsurg : 401 -407.

    • Search Google Scholar
  • Kruse, A.L., Luebbers, H.T., Grätz, K.W., Obwegeser, J.A.: Factors influencing survival of free-flap in reconstruction for cancer of the head and neck: A literature review. Microsurgery 30, 242–248 (2010).

    Obwegeser J.A. , 'Factors influencing survival of free-flap in reconstruction for cancer of the head and neck: A literature review ' (2010 ) 30 Microsurgery : 242 -248.

    • Search Google Scholar
  • Hirakawa, H., Hasegawa, Y., Hanai, N., Ozawa, T., Hyodo, I., Suzuki, M.: Surgical site infection in clean-contaminated head and neck cancer surgery: Risk factors and prognosis. Archives of Oto-Rhino-Laryngology DOI: 10.1007/s00405-012-2128-y (2012)

    Suzuki M. , '', in Archives of Oto-Rhino-Laryngology , (2012 ) -.

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 7 0 0
Jun 2021 0 0 0
Jul 2021 3 0 0
Aug 2021 9 0 0
Sep 2021 3 0 0
Oct 2021 1 0 0
Nov 2021 0 0 0